Neuroprotective Efficacy of a New Brain-Penetrating C-Abl Inhibitor in a Murine Parkinson’s Disease Model

PLoS ONE - United States
doi 10.1371/journal.pone.0065129
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Mitochondrial Division Inhibitor-1 Is Neuroprotective in the A53t-Α-Synuclein Rat Model of Parkinson’s Disease

Scientific Reports
Multidisciplinary
2017English

A Neuroprotective Role for Angiogenin in Models of Parkinson’s Disease

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2010English

Correction to “Neuroprotective Efficacy and Pharmacokinetic Behavior of Novel Anti-Inflammatory Para-Phenyl Substituted Diindolylmethanes in a Mouse Model of Parkinson’s Disease”

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2019English

Neuroprotective Effects and Mechanisms of Exercise in a Chronic Mouse Model of Parkinson’s Disease With Moderate Neurodegeneration

European Journal of Neuroscience
Neuroscience
2011English

Adoptive Immunotherapy of BCR-ABL-induced Chronic Myeloid Leukemia-Like Myeloproliferative Disease in a Murine Model

Blood
BiochemistryImmunologyCell BiologyHematology
2004English

Evaluation of the Efficacy of Dasatinib, a SRC/Abl Inhibitor, in Colorectal Cancer Cell Lines and Explant Mouse Model

PLoS ONE
Multidisciplinary
2017English

Neuroplasticity and Neuroprotective Effect of Treadmill Training in the Chronic Mouse Model of Parkinson’s Disease

Neural Plasticity
Neurology
2019English

Selenotranscriptomic Analyses Identify Signature Selenoproteins in Brain Regions in a Mouse Model of Parkinson’s Disease

PLoS ONE
Multidisciplinary
2016English

The New Metall-Beta-Lactamase’s Inhibitor Efficacy in a Model System in Vitro

Russian Journal of Infection and Immunity
Infectious DiseasesAllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy